The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Manfredi RizzoAli A. RizviKaspar Berneis Review Article 17 October 2008 Pages: 1 - 11
Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals Luigi BouchardGeneviève FaucherMarie-Claude Vohl Original Article 06 August 2008 Pages: 13 - 21
Ophthalmoplegia in diabetes mellitus: a retrospective study Domenico GrecoFrancesco GambinaFilippo Maggio Original Article 29 August 2008 Pages: 23 - 26
Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes Sudarshan K. VijayManish MishraK. Tripathi Original Article 29 August 2008 Pages: 27 - 33
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control Simona I. ChisalitaTorbjörn LindströmHans J. Arnqvist Original Article 06 September 2008 Pages: 35 - 42
Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes D. A. ChistiakovV. A. PotapovV. V. Nosikov Original Article 29 August 2008 Pages: 43 - 49
A single test procedure to diagnose gestational diabetes mellitus C. AnjalakshiV. BalajiV. Seshiah Original Article 02 October 2008 Pages: 51 - 54
Glycaemic variability and inflammation in subjects with metabolic syndrome Silvio BuscemiSalvatore VergaGiovanni Cerasola Original Article 26 September 2008 Pages: 55 - 61
Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan Okan BakinerMelek E. ErtorerNilgun G. Demirag Original Article 30 September 2008 Pages: 63 - 65
Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study G. De MattiaO. LaurentiA. Moretti Original Article Open access 22 November 2008 Pages: 67 - 73
Pioglitazone reduces monocyte activation in type 2 diabetes Dario PitoccoSimona GiubilatoGiovanni Ghirlanda Short Communication 27 September 2008 Pages: 75 - 77
